GT-008

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameGT-008

Drug Alias NameGT-008[177Lu]-GT008

ClassificationRadiation-emitting products > Radioactive therapeutic agentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyRadiation-emitting products > Nuclides > Lutetium > 177Lu +[4]

Mechanisms of ActionIonising radiation emittersAnti-Signal transducer CD24

TargetsSignal transducer CD24

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGlycotope Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesPentixapharm AG

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A